Effect of Region of Interest Size on the Repeatability of Quantitative Brain Imaging Biomarkers

In the repeatability analysis, when the measurement is the mean value of a parametric map within a region of interest (ROI), the ROI size becomes important as by increasing the size, the measurement will have a smaller variance. This is important in decision-making in prospective clinical studies of brain when the ROI size is variable, e.g., in monitoring the effect of treatment on lesions by quantitative MRI, and in particular when the ROI is small, e.g., in the case of brain lesions in multiple sclerosis. Thus, methods to estimate repeatability measures for arbitrary sizes of ROI are desired. We propose a statistical model of the values of parametric map within the ROI and a method to approximate the model parameters, based on which we estimate a number of repeatability measures including repeatability coefficient, coefficient of variation, and intraclass correlation coefficient for an ROI with an arbitrary size. We also show how this gives an insight into related problems such as spatial smoothing in voxel-wise analysis. Experiments are conducted on simulated data as well as on scan–rescan brain MRI of healthy subjects. The main application of this study is the adjustment of the decision threshold based on the lesion size in treatment monitoring.

[1]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[2]  Daniel Rueckert,et al.  Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.

[3]  P. Hluštík,et al.  Effects of spatial smoothing on fMRI group inferences. , 2008, Magnetic resonance imaging.

[4]  H. Kauczor,et al.  Treatment Monitoring in Gliomas: Comparison of Dynamic Susceptibility-Weighted Contrast-Enhanced and Spectroscopic MRI Techniques for Identifying Treatment Failure , 2011, Investigative radiology.

[5]  Brian D Ross,et al.  Predicting and monitoring cancer treatment response with diffusion‐weighted MRI , 2010, Journal of magnetic resonance imaging : JMRI.

[6]  Min Chen,et al.  Multi-parametric neuroimaging reproducibility: A 3-T resource study , 2011, NeuroImage.

[7]  N. Makris,et al.  Decreased volume of left and total anterior insular lobule in schizophrenia , 2006, Schizophrenia Research.

[8]  Brian B. Avants,et al.  Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..

[9]  V. Dousset,et al.  Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its Therapy , 2012, Neurotherapeutics.

[10]  Brian B. Avants,et al.  High-Dimensional Spatial Normalization of Diffusion Tensor Images Improves the Detection of White Matter Differences: An Example Study Using Amyotrophic Lateral Sclerosis , 2007, IEEE Transactions on Medical Imaging.

[11]  Joana Ramalho,et al.  Arterial spin labeling in neuroimaging. , 2010, World journal of radiology.

[12]  Anwar R. Padhani,et al.  Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy , 2010, Targeted Oncology.

[13]  Huiman X Barnhart,et al.  Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets. , 2009, Translational oncology.

[14]  Olivier Commowick,et al.  Imaging biomarkers in multiple Sclerosis: From image analysis to population imaging , 2016, Medical Image Anal..

[15]  Yuxi Pang,et al.  Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging. , 2012, Diagnostic and interventional radiology.

[16]  David Bonekamp,et al.  Diffusion tensor imaging in children and adolescents: Reproducibility, hemispheric, and age-related differences , 2007, NeuroImage.

[17]  Sung-Cheng Huang,et al.  Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  Jarkko Johansson,et al.  Automated Reference Region Extraction and Population-Based Input Function for Brain [11C]TMSX PET Image Analyses , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  A Gregory Sorensen,et al.  Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial. , 2015, Neuro-oncology.

[20]  W. Edelstein,et al.  The intrinsic signal‐to‐noise ratio in NMR imaging , 1986, Magnetic resonance in medicine.

[21]  A. Padhani Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions , 2002, Journal of magnetic resonance imaging : JMRI.

[22]  P. Wong,et al.  Susceptibility-weighted MRI in mild traumatic brain injury , 2015, Neurology.

[23]  A J Thompson,et al.  Survey of the distribution of lesion size in multiple sclerosis: implication for the measurement of total lesion load , 1997, Journal of neurology, neurosurgery, and psychiatry.

[24]  D. Parker,et al.  Signal-to-noise efficiency in magnetic resonance imaging. , 1990, Medical physics.

[25]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[26]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[27]  Derek K. Jones,et al.  The effect of filter size on VBM analyses of DT-MRI data , 2005, NeuroImage.

[28]  Bradford A Moffat,et al.  Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. van Buchem,et al.  Can arterial spin labeling detect white matter perfusion signal? , 2009, Magnetic resonance in medicine.

[30]  Moo K. Chung,et al.  A study of diffusion tensor imaging by tissue-specific, smoothing-compensated voxel-based analysis , 2009, NeuroImage.

[31]  Juan Hu Covariogram, Examples of , 2013 .

[32]  Susan A. Gauthier,et al.  Measuring longitudinal myelin water fraction in new multiple sclerosis lesions , 2015, NeuroImage: Clinical.

[33]  A. Alexander,et al.  Diffusion tensor imaging of the brain , 2007, Neurotherapeutics.

[34]  N. Andreasen,et al.  Anatomic and Functional Variability: The Effects of Filter Size in Group fMRI Data Analysis , 2001, NeuroImage.

[35]  P. LaViolette,et al.  Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity , 2010, Journal of magnetic resonance imaging : JMRI.

[36]  Manuel Desco,et al.  Assessment of the increase in variability when combining volumetric data from different scanners , 2009, Human brain mapping.

[37]  A. Londoño,et al.  Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis , 2014, Neurology: Neuroimmunology & Neuroinflamm.

[38]  M Filippi,et al.  Imaging biomarkers in multiple sclerosis , 2010, Journal of magnetic resonance imaging : JMRI.